Faculty Opinions recommendation of Experiences of closed-loop insulin delivery among pregnant women with Type 1 diabetes.

Author(s):  
Richard N Brown
Diabetes Care ◽  
2011 ◽  
Vol 34 (12) ◽  
pp. 2527-2529 ◽  
Author(s):  
H. R. Murphy ◽  
K. Kumareswaran ◽  
D. Elleri ◽  
J. M. Allen ◽  
K. Caldwell ◽  
...  

Diabetes Care ◽  
2018 ◽  
Vol 41 (7) ◽  
pp. 1391-1399 ◽  
Author(s):  
Zoe A. Stewart ◽  
Malgorzata E. Wilinska ◽  
Sara Hartnell ◽  
Leanne K. O’Neil ◽  
Gerry Rayman ◽  
...  

2017 ◽  
Vol 34 (10) ◽  
pp. 1461-1469 ◽  
Author(s):  
C. Farrington ◽  
Z. A. Stewart ◽  
K. Barnard ◽  
R. Hovorka ◽  
H. R. Murphy

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1065-P ◽  
Author(s):  
ANASTASIOS KOUTSOVASILIS ◽  
ALEXIOS SOTIROPOULOS ◽  
ANASTASIA ANTONIOU ◽  
VASILIOS KORDINAS ◽  
DESPINA PAPADAKI ◽  
...  

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 725-P
Author(s):  
SEMAH TAGOUGUI ◽  
NADINE TALEB ◽  
CORINNE SUPPERE ◽  
INÈS BOUKABOUS ◽  
VIRGINIE MESSIER ◽  
...  

2021 ◽  
Vol 14 (9) ◽  
pp. e243522
Author(s):  
Khulood Bukhari ◽  
Rana Malek

A 40-year-old woman used an open-source automated insulin delivery system to manage her type 1 diabetes (T1D) prior to conception. The code for building the iPhone application called ‘Loop’ that carried the software for the hybrid closed-loop controller was available online. Her glycated hemoglobin before conception was 6.4%. Between 6 and 12 weeks gestation, she spent 66% time-in-range (TIR), 28% time-above-range (TAR) and 6% time-below-range (TBR). Between 18 and 24 weeks gestation, she spent 68% TIR, 27% TAR and 5% TBR. During her third trimester, she spent 72% TIR, 21% TAR and 7% TBR. She delivered a healthy infant with no neonatal complications. Clinicians should be aware of this technology as it gains traction in the T1D community and seeks Food and Drug Administration approval.


Sign in / Sign up

Export Citation Format

Share Document